British pharmaceutical giant AstraZeneca said Thursday that a third, or “booster”, dose of its Covid-19 vaccine Vaxzevria “significantly” lifted antibody levels against the Omicron strain in a laboratory study. “Vaxzevria significantly boosted levels of antibodies ...
Online desk: New Zealand authorities on Monday said they had linked a 26-year-old man’s death to Pfizer Inc’s COVID-19 vaccine after the person suffered myocarditis, a rare inflammation of the heart muscle, after taking his ...
COVID-19 cases are surging in New South Wales and continue to rise in other parts of Australia as authorities warn transmission of the Omicron variant has a doubling time of around two days. It’s an ...
Online desk: The following is a summary of some recent studies on COVID-19. They include research that warrants further study to corroborate the findings and that has yet to be certified by peer review. Omicron ...